Schmid et al. reported that the KRAS and EGFR gene status in primary tumors and lymph node metastases were discordant in 25 (26%) and 6 (6.25%) patients among 96 patients, respectively [26]. The gene discussed is EGFR; the disease is metastatic malignant neoplasm in the lymph nodes.